Atossa Genetics Shares Outstanding 2012-2024 | ATOS
Atossa Genetics shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Atossa Genetics Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 126 |
| 2022 | 127 |
| 2021 | 117 |
| 2020 | 11 |
| 2019 | 8 |
| 2018 | 4 |
| 2017 | 1 |
| 2016 | 0 |
| 2015 | 0 |
| 2014 | 0 |
| 2013 | 0 |
| 2012 | 0 |
| 2011 | 0 |
| Atossa Genetics Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-09-30 | 126 |
| 2024-06-30 | 126 |
| 2024-03-31 | 125 |
| 2023-12-31 | 126 |
| 2023-09-30 | 126 |
| 2023-06-30 | 127 |
| 2023-03-31 | 127 |
| 2022-12-31 | 127 |
| 2022-09-30 | 127 |
| 2022-06-30 | 127 |
| 2022-03-31 | 127 |
| 2021-12-31 | 117 |
| 2021-09-30 | 127 |
| 2021-06-30 | 122 |
| 2021-03-31 | 93 |
| 2020-12-31 | 11 |
| 2020-09-30 | 10 |
| 2020-06-30 | 9 |
| 2020-03-31 | 9 |
| 2019-12-31 | 8 |
| 2019-09-30 | 9 |
| 2019-06-30 | 9 |
| 2019-03-31 | 7 |
| 2018-12-31 | 4 |
| 2018-09-30 | 5 |
| 2018-06-30 | 3 |
| 2018-03-31 | 0 |
| 2017-12-31 | 1 |
| 2017-09-30 | 1 |
| 2017-06-30 | 1 |
| 2017-03-31 | 0 |
| 2016-12-31 | 0 |
| 2016-09-30 | 0 |
| 2016-06-30 | 0 |
| 2016-03-31 | 0 |
| 2015-12-31 | 0 |
| 2015-09-30 | 0 |
| 2015-06-30 | 0 |
| 2015-03-31 | 0 |
| 2014-12-31 | 0 |
| 2014-09-30 | 0 |
| 2014-06-30 | 0 |
| 2014-03-31 | 0 |
| 2013-12-31 | 0 |
| 2013-09-30 | 0 |
| 2013-06-30 | 0 |
| 2013-03-31 | 0 |
| 2012-12-31 | 0 |
| 2012-09-30 | 0 |
| 2012-06-30 | 0 |
| 2012-03-31 | 0 |
| 2011-12-31 | |
| 2011-09-30 | 0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.155B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.416B | 24.94 |
| Intuitive Surgical (ISRG) | United States | $192.946B | 100.88 |
| Alcon (ALC) | Switzerland | $43.080B | 28.83 |
| Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
| IQVIA Holdings (IQV) | United States | $36.405B | 20.06 |
| IDEXX Laboratories (IDXX) | United States | $35.383B | 41.67 |
| DexCom (DXCM) | United States | $31.603B | 47.59 |
| Waters (WAT) | United States | $22.979B | 33.98 |
| STERIS (STE) | Ireland | $21.385B | 24.62 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.978B | 0.00 |
| Hologic (HOLX) | United States | $17.581B | 18.99 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.691B | 14.05 |
| Sysmex ADR (SSMXY) | Japan | $13.362B | 41.90 |
| Globus Medical (GMED) | United States | $11.588B | 29.34 |
| Penumbra (PEN) | United States | $9.412B | 92.19 |
| Masimo (MASI) | United States | $9.326B | 45.13 |
| Teleflex (TFX) | United States | $8.737B | 13.94 |
| Glaukos (GKOS) | United States | $7.499B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.035B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.735B | 26.84 |
| Veracyte (VCYT) | United States | $3.384B | 101.54 |
| Inari Medical (NARI) | United States | $3.018B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.803B | 16.18 |
| Nihon Kohden (NHNKY) | Japan | $2.421B | 18.39 |
| TransMedics (TMDX) | United States | $2.398B | 76.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.192B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.121B | 19.07 |
| Integra LifeSciences Holdings (IART) | United States | $1.901B | 9.93 |
| RxSight (RXST) | United States | $1.756B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.248B | 0.00 |
| Artivion (AORT) | United States | $1.244B | 82.44 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.875B | 14.87 |
| Paragon 28 (FNA) | United States | $0.856B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.739B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 36.74 |
| Mesa Laboratories (MLAB) | United States | $0.668B | 15.75 |
| AxoGen (AXGN) | United States | $0.635B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.634B | 0.00 |
| SiBone (SIBN) | United States | $0.546B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.533B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 31.04 |
| Pacific Biosciences Of California (PACB) | United States | $0.501B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.453B | 24.53 |
| Delcath Systems (DCTH) | United States | $0.379B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.289B | 0.00 |
| Inogen (INGN) | United States | $0.237B | 0.00 |
| Accuray (ARAY) | United States | $0.211B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.092B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.088B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |